Anokion

is a Switzerland-based biotechnology company that researches and develops antigen-specific immune tolerance therapies for the treatment of autoimmune diseases...
Read more
Anokion President & CEO: Deborah Geraghty

President & CEO

Deborah Geraghty

CEO Approval Rating

86/100

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$112.5M
Acquisitions
1

News

Jan 08, 2025
FinanzNachrichten
Anokion: Anokion SA: Anokion Announces Positive Symptom Data from its Phase 2 Trial Evaluating KAN-101 for the Treatment of Celiac Disease
Dec 19, 2024
FinanzNachrichten
Anokion: Anokion SA: Anokion Announces the Early Completion of Enrollment in the ACeD-it Phase 2 and the SynCeD Phase 2a Trials of KAN-101 for the Treatment of Celiac Disease
Sep 18, 2024
FinanzNachrichten
Anokion: Anokion SA: Anokion Announces New Data from the Phase 1 MoveS-it Study Supporting ANK-700 as a Novel, Potential Disease Modifying Treatment for Relapsing-Remitting Multiple Sclerosis
May 20, 2024
FinanzNachrichten
Anokion: Anokion SA: Anokion Announces New Clinical Data from the Phase 1b/2 ACeD-it Trial Supporting KAN-101 as a Potential Disease-Modifying Treatment for Celiac Disease
Oct 19, 2023
FinanzNachrichten
Anokion: Anokion SA: Anokion to Participate in BofA Healthcare Trailblazers Conference
Sep 19, 2023
FinanzNachrichten
Anokion: Anokion Announces Nature Biomedical Engineering Publication Further Validating its Immune Tolerance Approach to Treating Celiac Disease and Multiple Sclerosis
Sep 12, 2023
FinanzNachrichten
Anokion: Anokion SA: Anokion Announces Clinical Progress with KAN-101 and ANK-700
Sep 07, 2023
FinanzNachrichten
Anokion: Anokion SA: Anokion Strengthens its Senior Leadership with Promotions and New Appointment
Jun 15, 2023
FinanzNachrichten
Anokion: Anokion SA: Anokion Announces Publication in The Lancet Gastroenterology & Hepatology Highlighting Safety and Preliminary Effects of KAN-101 in Celiac Disease in its ACeD Phase 1 Clinical Trial
May 09, 2023
Clinical Trials Arena
Anokion: Encouraging results for Anokion's KAN-101 in coeliac disease

Anokion Competitors

1AnTolRx
2Apitope
3Toleranzia AB
4Protagen
5SuppreMol
6Kineta
7NexImmune
8Paragen Bio
9Baxalta
10Serimmune

Trending Companies